Evidence map›Paper›PMID 21715499›Full record

ArticleJournal of virology2011

Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection.

Shahram Salek-Ardakani, Magdalini Moutaftsi, Alessandro Sette, Michael Croft

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shahram Salek-ArdakaniLa Jolla Institute for Allergy and Immunology, Division of Immune Regulation, 9420 Athena Circle, San Diego, CA 92037, USA. ssalek@liai.org
Magdalini Moutaftsi
Alessandro Sette
Michael Croft
La Jolla Institute for Immunology · USVaccine Research Institute of San Diego · US

Funding

Regulation of T Cell Tolerance by OX40R01CA091837 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2002 to 2012
$2.5M
TNFR Members in T Cell Immunity to VacciniaR01AI067341 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2006 to 2010
$2.3M
LIGHT_HVEM_BTLA axis in protective anti_viral immunityR01AI087734 · NIAID · UNIVERSITY OF FLORIDA · PI SALEK-ARDAKANI, SHAHRAM · 2011 to 2015
$1.6M
T Cell Memory to Respiratory Viral InfectionsR21AI077079 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SALEK-ARDAKANI, SHAHRAM · 2007 to 2008
$515k
TNFR Members in T Cell Immunity to VacciniaR56AI067341 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2012 to 2012
$348k
NCI NIH HHS CA91837NCI NIH HHS R01 CA091837NIAID NIH HHS AI087734NIAID NIH HHS AI67341NIAID NIH HHS AI77079NIAID NIH HHS R01 AI067341NIAID NIH HHS R01 AI087734NIAID NIH HHS R21 AI077079NIAID NIH HHS R56 AI067341
6 · The paper itself

Abstract

One goal of vaccination is to promote development of mucosal effector cells that can immediately respond to peripheral infection. This is especially important for protection against viruses that enter the host through the respiratory tract. We show that targeting the OX40 costimulatory receptor (CD134) strongly promotes mucosal memory in the CD8 T cell compartment. Systemic injection of an agonist antibody to OX40 strongly enhanced development of polyfunctional effector CD8 T cells that were induced after intraperitoneal infection with a highly virulent strain of vaccinia virus. These cells were located in lymphoid organs and also the lung, and importantly, long-term memory CD8 T cells were maintained in the lung over 1 year. Anti-OX40 also boosted memory development when mice were vaccinated subcutaneously with viral peptide. These CD8 T cells were sufficient to provide protection from lethal respiratory infection with live vaccinia virus independent of CD4 T cells and antibody. Again, the CD8 T cell populations that were induced after secondary infection displayed polyfunctionality and were maintained in the lung for over a year. These data suggest that agonists to the OX40 costimulatory receptor represent potential candidates for incorporation into vaccines for respiratory viruses.

Indexed as

Immunologic MemoryAnimalsBody WeightCD8-Positive T-LymphocytesDisease Models, AnimalFemaleLungLymphocyte DepletionMiceMice, Inbred C57BLMice, KnockoutPoxviridae InfectionsReceptors, OX40Respiratory Tract InfectionsRodent DiseasesVaccinia virusReceptors, OX40Tnfrsf4 protein, mouse

Identifiers

PMID21715499
PMCPMC3165842
OpenAlexW2116157579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.